Effects of Immunotherapy: Clinical Trials

7 trials for Effects of Immunotherapy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 recruiting, 1 completed. 7 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 17Recruiting 6, Completed 1

Follow Effects of Immunotherapy: new trials by email Literature Review of Effects of Immunotherapy trials Research Report on Effects of Immunotherapy

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of TIL in Advanced Solid Tumors (DFGD)
GC203 TIL(gene-edited TIL) or autologous TILs - Advanced Solid Tumor, Tumor Infiltrating Lymphocytes
Early Phase 1RecruitingShanghai Juncell Therapeutics302023-04-012025-12-16
A Study of GC203 TIL in Advanced Gynecologic Tumors (10hospital)
Membrane Bound Cytokine Modified TIL - Advanced Gynecologic Tumors, TIL Engineered With Membrane-Binding Cytokine
Early Phase 1CompletedShanghai Juncell Therapeutics262022-03-102025-12-11
A Clinical Study on TIL for the Treatment of Advanced Solid Tumors
Tumor Infiltrating Lymphocytes - Advanced Solid Tumor, Tumor Infiltrating Lymphocytes
Early Phase 1RecruitingShanghai Juncell Therapeutics502021-12-102026-08-05
A Study of GC101 TIL in Advanced Breast Cancer (10hospital)
Tumor Infiltrating Lymphocytes (TIL) - Breast Cancer, Treatment Side Effects
Early Phase 1RecruitingShanghai Juncell Therapeutics502021-11-192025-12-11
A Study of GC201 TIL in Advanced Gynecologic Tumors (10hospital)
Signal Switch Receptor Modified TIL - Advanced Gynecologic Tumors, Signal Switch Receptor Modified TIL
Early Phase 1RecruitingShanghai Juncell Therapeutics502021-09-262025-12-11
A Study of GC101 TIL in Advanced Melanoma (10hospital)
Tumor Infiltrating Lymphocyte - Advanced Melanoma, Tumor Infiltrating Lymphocyte
Early Phase 1RecruitingShanghai Juncell Therapeutics502021-09-262025-12-11
A Study of GC101 TIL in Advanced Hepatobiliary-Pancreatic Cancers (10hospital)
Tumor Infiltrating Lymphocyte - Advanced Liver Cancers, Tumor Infiltrating Lymphocyte
Early Phase 1RecruitingShanghai Juncell Therapeutics502021-09-262025-12-11

Narrower conditions

Breast Neoplasms (1)

Broader conditions

Breast Diseases (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)  ·  Skin Diseases (1)  ·  Skin and Connective Tissue Diseases (1)

Sponsors

Shanghai Juncell Therapeutics (7)

Countries

China (7)

Top investigators

Qian Zhang (1)  ·  Wenlong Yu (1)